Quantcast
Home » Topics » generic drugs

Supreme Court rules generic drug makers cannot be held liable for defects

WASHINGTON (Reuters) – The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects. In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of…

Google+